Seric and local antibodies against a synthetic peptide of HPV16

By Dreyfus M.   Baldauf J.-J.   Ritter J.   Obert G.  

European Journal of Obstetrics & Gynecology and Reproductive Biology, Vol. 59, Iss. 2, 1995-04 ,pp. : 187-191

Elsevier

Access to resources Recommend Favorite

Role of the vaginal microbiological ecosystem and cytokine profile in the promotion of cervical dysplasia: a case–control study

By Behbakht Kian   Friedman Jennifer   Heimler Ira   Aroutcheva Alla   Simoes Jose   Faro Sebastian  

Infectious Diseases in Obstetrics and Gynecology, Vol. 10, Iss. 4, 2002-11 ,pp. : 181-186

Taylor & Francis Ltd

Access to resources Recommend Favorite

In vitro and in vivo evaluations of human papillomavirus type 16 (HPV16)-derived peptide-loaded dendritic cells (DCs) with a CpG oligodeoxynucleotide (CpG-ODN) adjuvant as tumor vaccines for immunotherapy of cervical cancer

By Wang Hua   Xu Hui   Lu Wei   Zhu Lin   Yu Yun   Hong Fan  

Archives of Gynecology and Obstetrics, Vol. 289, Iss. 1, 2014-01 ,pp. : 155-162

Springer Publishing Company

Access to resources Recommend Favorite

Determinants of response to intracervical prostaglandin E2 for cervical ripening

By Bortolus R.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 87, Iss. 2, 1999-12 ,pp. : 137-141

Elsevier

Access to resources Recommend Favorite

Implementation of prophylactic HPV vaccination: progress and future challenges

By Brabin Loretta   Kitchener Henry C   Stern Peter L  

Expert Review of Obstretrics and Gynecology, Vol. 5, Iss. 5, 2010-09 ,pp. : 591-603

Informa Healthcare

Access to resources Recommend Favorite